By  on February 5, 2010

Cosmedicine, a skin care range with over-the-counter grade actives, is working to formulate a potent rejuvenating antidote: expanded retail distribution.

In October, the New York-based private equity firm Vertex Capital Management purchased the struggling brand’s intellectual property, including the name, and product clinicals and inventory, from Cosmedicine’s lender, Laurus, after, the company that created the line, filed for bankruptcy. Vertex relaunched Cosmedicine under the corporate nameplate Costru Company. Laurus maintains a small equity stake in the new venture.

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus